ENERZAIR BREEZHALER inha 150/50/160mcg 90 pce

7680675960057 CH-67596 R03AL12 03.04.5.

Reimbursement limitations:

ENERZAIR

Pour le traitement d'entretien des patients souffrant d'asthme sévère qui ne sont pas suffisamment contrôlés …

ENERZAIR BREEZHALER inha 150/50/160mcg 90 pce
ENERZAIR BREEZHALER inha 150/50/160mcg 90 pce
ENERZAIR BREEZHALER inha 150/50/160mcg 90 pce
1 / 3
google

Details

Product number
6759602
CPT
-
Packaging group
90
Unit
Kapsel(n)
Composition
indacaterolum 150 µg ut indacateroli acetas, glycopyrronium 50 µg ut glycopyrronii bromidum, mometasoni furoas 160 µg, lactosum monohydricum 24..567 mg, magnesii stearas, Kapselhülle: hypromellosum, carrageenanum, kalii chloridum, E 172 (flavum), E 132, aqua purificata, cera carnauba, Drucktinte: aqua purificata, E 172 (nigrum), alcohol isopropylicus, propylenglycolum, hypromellosum pro capsula.

Articles (1)

Enerzair Breezhaler 150/50/160 μg, Hartkapsel mit Pulver zur Inhalation
Pulver
90
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
13/05/2025
Patient information leaflet
Français
13/05/2025
Patient information leaflet
Italien
13/05/2025
Professional SmPC
Allemand
13/05/2025
Professional SmPC
Français
13/05/2025
Professional SmPC
Italien
13/05/2025

Detailed composition

Substance Quantity Type Category
(N/A)
150.0 UG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
50.0 UG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
160.0 UG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FIMDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 222.30
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/01/2021

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
67596
Drug name
Enerzair Breezhaler, Hartkapsel mit Pulver zur Inhalation
Galenic form
KAHI
ATC Code
R03AL12
Authorization status
Z
Dispensation category
B
First authorization
24/09/2020
Authorization expiration date
31/12/9999
IT number
03.04.5.
Domain
Human medicine
Field of application
Asthma

Packaging details

Description (FR)
ENERZAIR BREEZHALER inha 150/50/160mcg 90 pce
Description (DE)
ENERZAIR BREEZHALER Inha 150/50/160mcg 90 Stk
Market launch
24/09/2020
Narcotic (BTM)
No

Other packaging sizes

ENERZAIR BREEZHALER inha 150/50/160mcg 30 pce
30 KAP
View
ENERZAIR BREEZHALER inha+capt 150/50/160mcg 30 pce
30 KAP
View